A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

It seemed simple enough: She was charged a subscription fee and a fee for the medication she ordered, semaglutide, which is basically generic Ozempic. She quickly noticed her food cravings and ...

Buying presents for family and friends, hanging up your festive decorations and—coming off Ozempic? It might not be how everybody is preparing for Christmas, but for those taking weight-loss ...

Since Ozempic was approved by the Food and Drug Administration (FDA) in 2017, the medication (and other GLP-1 agonists like it) has become famous for helping people lose a significant amount of ...

Weight loss, a possible treatment for opioid use disorder, and reduced risks for heart disease, stroke, and a slew of other ...

Microdosing Ozempic, a weight-loss drug, is gaining popularity, with users claiming benefits like reduced hunger and weight loss. Experts are cautious due to the lack of research, though some ...

Modern medical innovations continue to transform treatment approaches for chronic conditions, and Ozempic stands at the forefront of this revolutionary landscape. As a sophisticated pharmaceutical ...